Vjhemonc Podcast

Amyloidosis is a rare disease in which insoluble amyloid proteins are deposited in tissues or organs, resulting in organ damage.... The post Updates in the treatment and management of amyloidosis and the importance of the multidisciplinary team appeared first on VJHemOnc.

Over the years, the hemophilia treatment landscape has transformed, with novel agents aiming to improve patient care and quality of... The post Hemophilia: the current standard of care and the value of novel gene therapies appeared first on VJHemOnc.

Bruton’s tyrosine kinase (BTK) inhibitors have transformed the treatment landscape of chronic lymphocytic leukemia (CLL), with both covalent and non-covalent... The post CLL highlights at EHA 2023: latest advances with the use of BTK inhibitors appeared first on VJHemOnc.

In recent years, CAR-T cell therapy has transformed the myeloma treatment landscape and has provided a valuable option to patients... The post Myeloma highlights at EHA 2023: CARTITUDE-4 & CARTITUDE-1 updates & the use of MRD in clinical practice appeared first on VJHemOnc.

The treatment landscape of large B-cell lymphoma (LBCL) has transformed in recent years, with novel immunotherapies including bispecific antibodies and... The post Lymphoma highlights at EHA 2023: sequencing bispecifics & CAR-T cells, bridging therapy & toxicity management appeared first on VJHemOnc.

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April, 2023, and brought... The post iwCAR-T Session IV: CAR-T therapy in CLL: challenges, combination approaches and ongoing trials appeared first on VJHemOnc.

Therapeutic agents for patients with myelodysplastic syndromes (MDS) are currently under active investigation in clinical trials. The management of cytopenias,... The post MDS 2023 highlights: managing anemia in lower-risk MDS & overcoming treatment failure in higher-risk disease appeared first on VJHemOnc.

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April, 2023, and brought... The post iwCAR-T Session III: CAR-T therapy in AML: ongoing challenges and strategies to improve patient outcomes appeared first on VJHemOnc.

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April, 2023, and brought...

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April, 2023, and brought... The post iwCAR-T Session I: CAR-T therapy in lymphoma and the role of BiTEs appeared first on VJHemOnc.

The 16th International Workshop on Multiple Myeloma (iwMyeloma) 2023 took place in Madrid, Spain, and brought together leading clinicians and... The post iwMyeloma Session III: reaching a cure for multiple myeloma and concepts that need to be addressed appeared first on VJHemOnc.

Myeloproliferative neoplasms (MPNs) represent a heterogeneous group of diseases which remain a challenge to treat. While there have been several... The post The current role of stem cell transplantation in MPNs & how this may change with novel agents appeared first on VJHemOnc.

The 16th International Workshop on Multiple Myeloma (iwMyeloma) 2023 took place in Madrid, Spain, and brought together leading clinicians and... The post iwMyeloma Session II: the tumor microenvironment and mechanisms of resistance to targeted therapies appeared first on VJHemOnc.

The 16th International Workshop on Multiple Myeloma (iwMyeloma) 2023 took place in Madrid, Spain, and brought together leading clinicians and... The post iwMyeloma Session I: genomics of high-risk and smoldering multiple myeloma appeared first on VJHemOnc.

Allogeneic stem cell transplantation (alloSCT) remains a valuable treatment option for fit patients with acute myeloid leukemia (AML), and the... The post The important role of transplantation in AML: improving outcomes for patients & the value of pre-transplant MRD appeared first on VJHemOnc.

Although several novel agents have been implemented in the treatment of Hodgkin and non-Hodgkin lymphoma (HL; NHL), chemotherapy remains the... The post Insights into the changing role of chemotherapy in lymphoma appeared first on VJHemOnc.

Recently, the International Consensus Classification (ICC) and World Health Organization (WHO) classification systems for myelodysplastic syndromes (MDS) were updated and... The post Comparing the ICC and WHO classifications for MDS and their impact on clinical practice appeared first on VJHemOnc.

CAR-T cell therapy represents a major breakthrough in the treatment of hematological malignancies, including multiple myeloma, non-Hodgkin lymphoma (NHL), and... The post Managing and treating toxicities associated with CAR-T therapy: CRS, ICANS & infections appeared first on VJHemOnc.

Over the years, the treatment landscape of B-cell acute lymphoblastic leukemia (B-ALL) has transformed with the implementation of novel immunotherapies,... The post The growing role of immunotherapy in the treatment of ALL & moving away from stem cell transplantation appeared first on VJHemOnc.

In recent years, novel immunotherapies, including CAR-T cell therapy, have greatly improved treatment options for patients with hematological malignancies. Although CAR-T... The post The current status of CAR-T therapy in CLL and challenges in this space appeared first on VJHemOnc.